XYMOGEN is a pioneering company in the healthcare industry, dedicated to providing high-quality nutraceuticals and functional medicine education. Founded in 2003 and headquartered in the United States, the company's mission goes beyond traditional health sciences. With a state-of-the-art 136,000-square foot manufacturing facility in Orlando, Florida, XYMOGEN adheres to the highest good manufacturing practices (GMP) standards and boasts several formulas that are NSF's Certified for Sport®.
The company's commitment to quality is evident in its operations, which are characterized by stringent quality systems and significant investments in top-of-the-line analytical equipment. This dedication to excellence includes pioneering ePedigree product tracking to ensure the integrity of its products. XYMOGEN emphasizes the importance of the doctor-patient relationship, promoting the use of its formulas under the careful guidance of a licensed healthcare practitioner and purchased from trusted sources to uphold the commitment to quality.
XYMOGEN's support for healthcare practitioners is showcased through its offerings such as dynamic events, integrative pharmacy, MedPax daily dose packs, EMR/EHR integrations, continuing education seminars, and opportunities for CME credits through XYMOGEN and WholeScripts.
The company received a significant $2.80M Venture Round investment on 04 April 2011, highlighting investor confidence in its mission. By continuously striving to redefine the healthcare landscape and elevate personalized healthcare, XYMOGEN invites partners to join them in their quest for wellness.